PPR-137 - Pharmacist Prescribing Support for Antiviral Drugs for New Coronavirus Infections in Outpatient Fever Clinics

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-137
• By: SATOMI, Machiko (Daidainooka Clinic, Japan)
• Co-author(s): Ms Machiko Satomi (Daidainooka Clinic, Asahikawa, Japan)
  MD Yasushi Abe (Daidainooka Clinic, Asahikawa, Japan)
  
• Abstract:

  [Introduction]
  Novel coronavirus infection (COVID-19) is an emerging infectious disease that was reported as an endemic pneumonia in Wuhan, Hubei Province, China, around December 2019.
  In Japan, oral monuravir (M) was launched in December 2021, nilmatrelvir/ritonavir (N) in February 2022, and encitrelvir (E) in November 2022.
  N should be..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login